Amphotericin B sodium

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameAmphotericin B sodium
Drug Alias NameCorifungin
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of ActionErgosterol bindersCell membrane permeability enhancers
TargetsErgosterol
Therapy Area/IndicationsLeishmaniasisAmebiasisMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAcea Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesAcea Biotech Inc
Inactive CompaniesN/A
Active IndicationsLeishmaniasisAmebiasisMycoses
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A